Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marina,Tuzova

第一单位： The Pulmonary Center, Boston University School of Medicine Boston, MA, USA.

作者： Marina,Tuzova ^[1] ; Jyh-Chang,Jean ^[1] ; Rebecca P,Hughey ^[2] ; Lou Ann S,Brown ^[3] ; William W,Cruikshank ^[1] ; Jun,Hiratake ^[4] ; Martin,Joyce-Brady ^[1]

作者单位： The Pulmonary Center, Boston University School of Medicine Boston, MA, USA. ^[1] Department of Medicine, University of Pittsburgh Pittsburgh, PA, USA. ^[2] Department of Pediatrics, Emory University School of Medicine Atlanta, GA, USA. ^[3] Institute for Chemical Research, Kyoto University Kyoto, Japan. ^[4]

关键词 GGsTop IL-13 asthma glutathione lung lining fluid

DOI 10.3389/fphar.2014.00179

PMID 25132819

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览18

Frontiers in pharmacology

2014年5卷

179页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除